FDA Brief

Company record

FitRX, LLC dba AM RX

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about FitRX, LLC dba AM RX.

Warning letters

  1. FitRX, LLC dba AM RX

    FDA warned telehealth seller AM RX that its website misbrands compounded semaglutide and tirzepatide with false and misleading claims.

    Medium